Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Working Capital to Net Assets Ratio

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Working Capital to Net Assets ratio of -2.1% as of June 2026. Working capital of $-2.88 Million (current assets of $69.18K minus current liabilities of $2.94 Million) is measured against net assets of $137.77 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Drugs Made In America Acquisition Corp. defensive interval ratio to measure how many days the company can operate on defensive assets alone.